Evidence map›Paper›PMID 37508187›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Symptoms, Treatment, and Outcomes of COVID-19 Patients Coinfected with

Lidia Oana Stămăteanu, Ionela Larisa Miftode, Claudia Elena Pleșca, Olivia Simona Dorneanu, Manuel Florin Roșu, Ioana Diandra Miftode, Maria Obreja, Egidia Gabriela Miftode

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Healthcare-AssociatedMicroorganisms · 2025
    Article
  2. Review
  3. "Antibiotics (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Lidia Oana StămăteanuDepartment of Internal Medicine II, Faculty of Medicine, University of Medicine and Pharmacy Gr. T. Popa, 700115 Iași, Romania.
Ionela Larisa MiftodeDepartment of Internal Medicine II, Faculty of Medicine, University of Medicine and Pharmacy Gr. T. Popa, 700115 Iași, Romania.ORCID 0000-0003-4131-1019
Claudia Elena PleșcaDepartment of Internal Medicine II, Faculty of Medicine, University of Medicine and Pharmacy Gr. T. Popa, 700115 Iași, Romania.
Olivia Simona Dorneanu"St. Parascheva" Clinical Hospital of Infectious Diseases, 700116 Iași, Romania.ORCID 0000-0001-7720-4499
Manuel Florin Roșu"St. Parascheva" Clinical Hospital of Infectious Diseases, 700116 Iași, Romania.
Ioana Diandra MiftodeDepartment of Radiology, "St. Spiridon" Emergency Clinical Hospital, 700111 Iași, Romania.
Maria ObrejaDepartment of Internal Medicine II, Faculty of Medicine, University of Medicine and Pharmacy Gr. T. Popa, 700115 Iași, Romania.
Egidia Gabriela MiftodeDepartment of Internal Medicine II, Faculty of Medicine, University of Medicine and Pharmacy Gr. T. Popa, 700115 Iași, Romania.
Grigore T. Popa University of Medicine and Pharmacy · ROSpitalul Clinic Judeţean de Urgenţe "Sf. Spiridon" Iaşi · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Coronavirus disease 2019 (COVID-19) pandemic has brought new challenges across medical disciplines, particularly in infectious disease medicine. In Romania, the incidence of SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) infection increased dramatically since March 2020 until March 2022. Antibiotic administration for pulmonary superinfections in COVID-19 intensified and, consequently, increased rates of

Indexed as

antibiotic stewardshipantimicrobial resistanceClostridioides difficile infectionco-infectionsSARS-CoV-2

Identifiers

PMID37508187
PMCPMC10375993
OpenAlexW4381741901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.